3705. Risk factors and early recurrence patterns following curative-intent resection of distal cholangiocarcinoma.
Lee I, Seo Y, Choi GW, Chae YS, Yun WG, Han Y, Jung HS, Cho YJ, Kwon W, Jang JY, Park JS.
HPB (Oxford). 2025 Oct 24:S1365-182X(25)01669-7.Link
3704. Appropriate extent of lymph node dissection in patients with muscle-invasive gallbladder cancer.
Yun WG, Han Y, Chae YS, Cho YJ, Jung HS, Park JS, Jang JY, Kwon W.
HPB (Oxford). 2025 Aug 21:S1365-182X(25)01581-3.Link
3703. Concept of Depth of Invasion can Improve Staging Performance in Patients with Resected Distal Cholangiocarcinoma: Validation of the American Joint Committee on Cancer Staging System.
Yun WG, Chae YS, Han Y, Cho YJ, Jung HS, Kwon W, Park JS, Kim H, Lee KB, Jang JY.
3702. Evaluating Tumor Regression and Survival Outcomes in Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment according to CAP Grading System: Clinical Usefulness and Limitations.
Choi GW, Seo Y, Lee I, Chae YS, Yun WG, Han Y, Jung HS, Cho YJ, Kwon W, Park JS, Jang JY.
3701. Evaluation of feasibility and clinical outcomes of robot-assisted pancreaticoduodenectomy after neoadjuvant treatment for patients with advanced pancreatic ductal adenocarcinoma: a retrospective propensity score-matched cohort study.
Kim HE, Jung HS, Han Y, Chae YS, Yun WG, Cho YJ, Kwon W, Park JS, Jang JY.
3699. Comparison of Pancreatic Fistula Between Robotic-Assisted and Open Pancreatoduodenectomy: A Comprehensive Evaluation Using an Alternative Fistula Risk Score.
Assawasirisin C, Han Y, Jung HS, Yun WG, Chae YS, Kwon W, Park JS, Jang JY.